Log in | Register

Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events

J. R. Zahar| M. Garrouste-Orgeas| A. Vesin| C. Schwebel| A. Bonadona| F. Philippart| C. Ara-Somohano| B. Misset| J. F. Timsit
Original
Volume 39, Issue 12 / December , 2013

Pages 2153 - 2160

Abstract

Contact isolation of infected or colonised hospitalised patients is instrumental to interrupting multidrug-resistant organism (MDRO) cross-transmission. Many studies suggest an increased rate of adverse events associated with isolation. We aimed to compare isolated to non-isolated patients in intensive care units (ICUs) for the occurrence of adverse events and medical errors.

Methods

We used the large database of the Iatroref III study that included consecutive patients from three ICUs to compare the occurrence of pre-defined medical errors and adverse events among isolated vs. non-isolated patients. A subdistribution hazard regression model with careful adjustment on confounding factors was used to assess the effect of patient isolation on the occurrence of medical errors and adverse events.

Results

Two centres of the Iatroref III study were eligible, an 18-bed and a 10-bed ICU (nurse-to-bed ratio 2.8 and 2.5, respectively), with a total of 1,221 patients. After exclusion of the neutropenic and graft transplant patients, a total of 170 isolated patients were compared to 980 non-isolated patients. Errors in insulin administration and anticoagulant prescription were more frequent in isolated patients. Adverse events such as hypo- or hyperglycaemia, thromboembolic events, haemorrhage, and MDRO ventilator-associated pneumonia (VAP) were also more frequent with isolation. After careful adjustment of confounders, errors in anticoagulant prescription [subdistribution hazard ratio (sHR) = 1.7, p = 0.04], hypoglycaemia (sHR = 1.5, p = 0.01), hyperglycaemia (sHR = 1.5, p = 0.004), and MDRO VAP (sHR = 2.1, p = 0.001) remain more frequent in isolated patients.

Conclusion

Contact isolation of ICU patients is associated with an increased rate of some medical errors and adverse events, including non-infectious ones.

Keywords

References

  1. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24:362–386
    • View reference on PubMed
    • View reference on publisher's website
  2. Siegel JD, Rhinehart E, Jackson M, Chiarello L (2007) 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 35:S65–S164
    • View reference on PubMed
    • View reference on publisher's website
  3. Siegel JD, Rhinehart E, Jackson M, Chiarello L (2007) Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 35:S165–S193
    • View reference on PubMed
    • View reference on publisher's website
  4. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth G, Lai R, Ebrahim S (2004) Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 329:533
    • View reference on PubMed
    • View reference on publisher's website
  5. Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Cookson B, Shaw S, Kibbler C, Singer M, Bellingan G, Wilson AP (2005) Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 365:295–304
    • View reference on PubMed
  6. Raineri E, Crema L, De Silvestri A, Acquarolo A, Albertario F, Carnevale G, Latronico N, Petrosillo N, Tinelli C, Zoncada A, Pan A (2007) Meticillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis. J Hosp Infect 67:308–315
    • View reference on PubMed
    • View reference on publisher's website
  7. Lucet JC, Paoletti X, Lolom I, Paugam-Burtz C, Trouillet JL, Timsit JF, Deblangy C, Andremont A, Regnier B (2005) Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 31:1051–1057
  8. Huskins WC, Huckabee CM, O’Grady NP, Murray P, Kopetskie H, Zimmer L, Walker ME, Sinkowitz-Cochran RL, Jernigan JA, Samore M, Wallace D, Goldmann DA (2011) Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 364:1407–1418
    • View reference on PubMed
    • View reference on publisher's website
  9. Evans HL, Shaffer MM, Hughes MG, Smith RL, Chong TW, Raymond DP, Pelletier SJ, Pruett TL, Sawyer RG (2003) Contact isolation in surgical patients: a barrier to care? Surgery 134:180–188
    • View reference on PubMed
    • View reference on publisher's website
  10. Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN (2009) Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 37:85–93
    • View reference on PubMed
    • View reference on publisher's website
  11. Stelfox HT, Bates DW, Redelmeier DA (2003) Safety of patients isolated for infection control. JAMA 290:1899–1905
    • View reference on PubMed
    • View reference on publisher's website
  12. Garrouste-Orgeas M, Timsit JF, Vesin A, Schwebel C, Arnodo P, Lefrant JY, Souweine B, Tabah A, Charpentier J, Gontier O, Fieux F, Mourvillier B, Troche G, Reignier J, Dumay MF, Azoulay E, Reignier B, Carlet J, Soufir L (2010) Selected medical errors in the intensive care unit: results of the IATROREF study: parts I and II. Am J Respir Crit Care Med 181:134–142
    • View reference on PubMed
    • View reference on publisher's website
  13. Garrouste-Orgeas M, Soufir L, Tabah A, Schwebel C, Vesin A, Adrie C, Thuong M, Timsit JF (2012) A multifaceted program for improving quality of care in intensive care units: iatroref study. Crit Care Med 40:468–476
    • View reference on PubMed
    • View reference on publisher's website
  14. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE (1981) APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 9:591–597
    • View reference on PubMed
    • View reference on publisher's website
  15. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963
    • View reference on PubMed
    • View reference on publisher's website
  16. Timsit JF, Fosse JP, Troche G, De Lassence A, Alberti C, Garrouste-Orgeas M, Bornstain C, Adrie C, Cheval C, Chevret S (2002) Calibration and discrimination by daily logistic organ dysfunction scoring comparatively with daily sequential organ failure assessment scoring for predicting hospital mortality in critically ill patients. Crit Care Med 30:2003–2013
    • View reference on PubMed
    • View reference on publisher's website
  17. Calvino Gunther S, Schwebel C, Vesin A, Remy J, Dessertaine G, Timsit JF (2009) Interventions to decrease tube, line, and drain removals in intensive care units: the FRATER study. Intensive Care Med 35:1772–1776
  18. de Lassence A, Alberti C, Azoulay E, Le Miere E, Cheval C, Vincent F, Cohen Y, Garrouste-Orgeas M, Adrie C, Troche G, Timsit JF (2002) Impact of unplanned extubation and reintubation after weaning on nosocomial pneumonia risk in the intensive care unit: a prospective multicenter study. Anesthesiology 97:148–156
    • View reference on PubMed
    • View reference on publisher's website
  19. Darmon M, Timsit JF, Francais A, Nguile-Makao M, Adrie C, Cohen Y, Garrouste-Orgeas M, Goldgran-Toledano D, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Souweine B, Azoulay E (2010) Association between hypernatraemia acquired in the ICU and mortality: a cohort study. Nephrol Dial Transpl 25:2510–2515
    • View reference on publisher's website
  20. Zahar JR, Nguile-Makao M, Francais A, Schwebel C, Garrouste-Orgeas M, Goldgran-Toledano D, Azoulay E, Thuong M, Jamali S, Cohen Y, de Lassence A, Timsit JF (2009) Predicting the risk of documented ventilator-associated pneumonia for benchmarking: construction and validation of a score. Crit Care Med 37:2545–2551
    • View reference on PubMed
    • View reference on publisher's website
  21. Beyersmann J, Schumacher M (2008) Time-dependent covariates in the proportional subdistribution hazards model for competing risks. Biostatistics 9:765–776
    • View reference on PubMed
    • View reference on publisher's website
  22. Loveday HP, Pellowe CM, Jones SR, Pratt RJ (2006) A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996–2004): report to the Joint MRSA Working Party (Subgroup A). J Hosp Infect 63(Suppl 1):S45–S70
    • View reference on PubMed
    • View reference on publisher's website
  23. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, Duckworth GJ, Lai R, Ebrahim S (2003) Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess 7:1–194
    • View reference on PubMed
  24. Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, Andremont A, Arlet G, Buu-Hoi A, Carlet J, Decre D, Gottot S, Gutmann L, Joly-Guillou ML, Legrand P, Nicolas-Chanoine MH, Soussy CJ, Wolf M, Lucet JC, Aggoune M, Brucker G, Regnier B (2010) Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med 170:552–559
    • View reference on PubMed
    • View reference on publisher's website
  25. Harbarth S, Masuet-Aumatell C, Schrenzel J, Francois P, Akakpo C, Renzi G, Pugin J, Ricou B, Pittet D (2006) Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 10:R25
    • View reference on PubMed
    • View reference on publisher's website
  26. Saint S, Higgins LA, Nallamothu BK, Chenoweth C (2003) Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 31:354–356
    • View reference on PubMed
    • View reference on publisher's website
  27. Kirkland KB, Weinstein JM (1999) Adverse effects of contact isolation. Lancet 354:1177–1178
    • View reference on PubMed
    • View reference on publisher's website
  28. Lesko LM, Kern J, Hawkins DR (1984) Psychological aspects of patients in germ-free isolation: a review of child, adult, and patient management literature. Med Pediatr Oncol 12:43–49
    • View reference on PubMed
    • View reference on publisher's website
  29. Klein BS, Perloff WH, Maki DG (1989) Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med 320:1714–1721
    • View reference on PubMed
    • View reference on publisher's website
  30. Bouadma L, Mourvillier B, Deiler V, Le Corre B, Lolom I, Regnier B, Wolff M, Lucet JC (2010) A multifaceted program to prevent ventilator-associated pneumonia: impact on compliance with preventive measures. Crit Care Med 38:789–796
    • View reference on PubMed
    • View reference on publisher's website
  31. Ammerlaan HS, Troelstra A, Kruitwagen CL, Kluytmans JA, Bonten MJ (2009) Quantifying changes in incidences of nosocomial bacteraemia caused by antibiotic-susceptible and antibiotic-resistant pathogens. J Antimicrob Chemother 63:1064–1070
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement